In very-high-risk patients with vascular disease, evolocumab slightly reduces nonfatal MI but not mortality (FOURIER)

In very-high-risk patients with vascular disease, evolocumab slightly reduces nonfatal MI but not mortality (FOURIER) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central